Progression-Free Survival in MM when Treating with Isatuximab

Progression-Free Survival in MM when Treating with Isatuximab

User Photo
obr

1 year
143 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Paul Richardson, MD, Clinical Program Leader, Director of Clinical Research, Jerome Lipper Multiple Myeloma, Institute Physician, Harvard Medical School discusses the prolonged progression-free survival in patients with relapsed/refractory multiple myeloma (MM) if treated with isatuximab.
Up Next Autoplay